Snowden Capital Advisors LLC Amneal Pharmaceuticals, Inc. Transaction History

Snowden Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $6,087 - $7,633	-1,561 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $6,165 - $9,131	1,561 New	1,561 $7,000
Q1 2020 Jan 08, 2024	SELL	$2.46 - $5.35 $384,006 - $835,135	-156,100 Closed	0 $0
Q3 2019 Jan 08, 2024	SELL	$2.29 - $7.1 $1.93 Million - $5.99 Million	-843,900 Reduced 84.39%	156,100 $4.53 Million
Q2 2019 Jan 08, 2024	BUY	$6.44 - $14.29 $6.44 Million - $14.3 Million	1,000,000 New	1,000,000 $11.2 Million

186

137M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.